Johnson & Johnson agrees to stop selling opioids nationwide in $230 million settlement with New York state

New York Attorney General Letitia James announced on Saturday that Johnson & Johnson has agreed to halt sales of opioids nationwide in a $230 million settlement with New York state.

As part of the settlement, the company will resolve opioids-related claims and allocate payments over nine years. It could also pay $30 million more in the first year if the state executive chamber signs into law new legislation creating an opioid settlement fund, according to the press release from James' office.

The settlement follows years of lawsuits by states, cities and counties against major pharmaceutical companies over the opioid crisis, which has killed nearly 500,000 people in the U.S. in the last couple decades.

Governments have argued that companies over-prescribed the drugs, causing people to become addicted and abuse other illegal forms of opioids, while companies have said they've distributed the necessary amount of the product to help people with medical issues.

"The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids," James said in a statement.

Leave a Comment